Age-dependent risks in genetic counseling for spinocerebellar ataxia type 2

Clinical Genetics

Volumn 74, Issue 6, 2008, Pages 571-573

  Almaguer, Mederos ^a   Proenza, C L ^b   Rodríguez, Almira ^b   Escalona, Batallán ^b   Santos, Falcón ^b   Martínez, Góngora ^b   Cuello, Almarales ^b   Velásquez, Pérez ^b   Paneque, Herrera ^b  

^a Luis Enrique Almaguer Mederos   (Cuba)

^b Center for Investigation and Rehabilitation of Hereditary Ataxias (CIRAH)   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ATAXIA; CEREBELLAR ATAXIA; DYSARTHRIA; DYSMETRIA; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LETTER; MOTOR DYSFUNCTION; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE; SPINOCEREBELLAR ATAXIA TYPE 2; TREMOR;

EID: 56749179485     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2008.01073.x     Document Type: Letter

References (17)

1. Gatchel JR, Zoghbi HY. Diseases of unstable repeat expansion: Mechanisms and common principles. Nat Rev Genet 2005: 6 (10): 743-755.
2. Harper PS, Newcombe RG. Age at onset and life table risks in genetic counselling for Huntington's disease. J Med Genet 1992: 29 (4): 239-242.
3. Sequeiros J Machado-Joseph disease: Epidemiology, genetics and genetic epidemiology. In: Lechtenberg R, (ed.). Handbook of cerebellar diseases. New York, NY: Dekker, 1993: 345-351.
4. Imbert G, Saudou F, Yvert G et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet 1996: 14: 285-291.
5. Orozco G, Nodarse FA, Auburger G. Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguín, Cuba. Neurology 1990: 40: 1369-1375.
6. Pulst SM, Nechiporuk A, Nechiporuk T et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet 1996: 14: 269-276.
7. Bürk K, Abele M, Fetter M et al. Autosomal dominant cerebellar ataxia type I Clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain 1996: 119: 1497-1505.
8. Tang B, Liu Ch, Shen L et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7 and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol 2000: 57: 540-544.
9. Lee WY, Jin DK, Oh MR et al. Frequency analysis and clinical characterization of spinocerebellar ataxia type 1, 2, 3, 6 and 7 in Korean patients. Arch Neurol 2003: 60: 858-863.
10. Murqod UA, Saleem Q, Anand A, Brahmachari SK, Jain S, Muthane UB. A clinical study of patients with genetically confirmed Huntington's disease from India. J Neurol Sci 2001: 190 (1-2): 73-78.
11. Nance MA, Myers RH. Juvenile onset Huntington's disease-clinical and research perspectives. Ment Retard Dev Disabil Res Rev 2001: 7 (3): 153-157.
12. Folstein SE, Leigh RJ, Parhad IM, Folstein M. The diagnosis of Huntington's disease. Neurology 1986: 36: 1279-1283.
13. DeStefano AL, Farrer LA, Maciel P et al. Gender equality in Machado-Joseph disease. Nat Genet 1995: 11: 118-119.
14. Velázquez PL, Santos FN, García R, Paneque HM, Hechavarría PR. Epidemiología de la ataxia hereditaria cubana. Rev Neurol 2001: 32 (7): 606-611.
15. Leznicki P Aggregation and toxicity of the proteins with polyQ repeats. Postepy Biochem 2005: 51 (2): 215-222.
16. Chai Y, Wu L, Griffin JD, Paulson HL. The role of protein composition in specifying nuclear inclusion formation in polyglutamine diseases. J Biol Chem 2001: 276 (48): 44889-44897.
17. Nozaki K, Onodera O, Takano H, Tsuji S. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation. Neuroreport 2001: 12 (15): 3357-3364.